Biocompare Releases Documentary on Antibody Validation Challenges

Thursday, June 15, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

SOUTH SAN FRANCISCO, Calif., June 15, 2017 /PRNewswire/ -- Biocompare, the leading digital global resource for the life science

industry, today released its documentary on "Reproducibility Issues in Life Science Research: Antibody Validation Challenges ".  The goal of the documentary is to bring together all key stakeholders—researchers, universities/institutions, antibody sellers/manufacturers,
publishers, societies, and funding agencies—to acknowledge that issues with antibody validation do exist, to raise awareness on how they can contribute to irreproducible data, and to bring to light ongoing initiatives and potential solutions.

The film features more than 20 thought leaders and stakeholders who express their concerns about current practices in antibody validation and propose solutions that they hope will be implemented by the life science community.

"I am pleased to have been actively involved in producing this documentary," says Mike Okimoto, Ph.D., Chief Content Officer at Compare Networks. "Antibody validation and data irreproducibility is indeed a crisis. But at the same time, it does present an opportunity for all of us to come together and improve the way we do science. Through this documentary we hope to highlight other factors that contribute to data irreproducibility in the lab and bring together both ideas and people to make a change."

According to NYU faculty member and participant, Dr. Pratip Chattopadhyay, "the film is a very timely, thought-provoking, and thorough review of a very real problem in the scientific research community. It reviews the major issue contributing to reproducibility well, and surveys and assesses efforts to find a solution."

A 2015 Biocompare Antibody Market Report estimated the antibody market for life science research to be approximately $2.5 billion with a 3% per annum expected growth. "Antibodies are a vital business, and we are happy to be working alongside the leading providers and manufacturers on this timely and relevant topic," says Joan Boyce, VP & GM at Biocompare. "Their participation and support was critical to the making of this documentary, and we appreciate their candid feedback and the initiatives they are undertaking to help tackle reproducibility."

For more information on this Biocompare documentary on "Reproducibility Issues in Life Science Research: Antibody Validation Challenges" please visit

About Biocompare

Biocompare, a Division of CompareNetworks, Inc., is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative resource that enables them to make better product, technology, and service purchasing decisions. Produced by scientists, Biocompare's mission is to provide free, time-saving services to life science researchers, allowing scientists to find and learn about the technologies that drive discovery. Biocompare continually strives to serve the life science community by providing new and improved online services that facilitate product discovery and technology education. For more information, please visit

Biocompare Division of Compare Networks, Inc.395 Oyster Point Blvd, Suite 321South San Francisco, CA 94080


To view the original version on PR Newswire, visit:

SOURCE Biocompare, Inc.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store